BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below.
GENERAL COMMENTS
The title was clearly written on the abstract but not in the main document. The title in the main document doesn't include the design. Participant timeline and informed consent material are not attached 
REVIEWER

VERSION 1 -AUTHOR RESPONSE
Reviewer: 1
The title was clearly written on the abstract but not in the main document. The title in the main document doesn't include the design.
The title of the manuscript submitted is: "Thiamine dose response in human milk with supplementation among lactating women in Cambodia: study protocol for a double-blind, four-parallel arm randomized controlled trial".
The study design is re-"This is a double-blind, four-parallel arm randomized controlled trial…" Participant timeline and informed consent material are not attached
The participant timeline is included as Figure 1 . We have attached the study consent form as Supplementary File for this re-submission.
Reviewer: 2 I congratulate the authors for this interesting study protocol. It will be interesting to see the related results published.
Thank you, and thank you for reviewing the protocol manuscript.
Reviewer: 3
The manuscript under review by Whitfield et al. is well written and should be considered for publication after some minor comments have been addressed: -L43ff: if the word count allows it would be very informative to add the actual time points for sample collection of the specimen.
The abstract word count is 300, and the original submission had exactly 300 words. We have added the timepoints in red-coloured text, however, since different data/samples are collected at different timepoints, this brought the abstract to 317 words.
-L165-176: While the test and the time of administering the test has been noted, please also add the target group (infant, mothers, etc…) for clarification for the reader who is less familiar with these approaches.
The secondary outcomes listed here are all cognitive development and neurological tests that will administered with the infants in the study. We have updated the outcomes accordingly; please see red-coloured text.
-L180ff: Please add your study population to the Study design and setting paragraph.
Thank you. We have updated the first sentence of this paragraph to read: "This is a double-blind, fourparallel arm randomized controlled trial among lactating women and their newborn infants."
-Eligibility: are the women apparently healthy? Any restrictions on illness? Chronic diseases?
The eligibility criteria are as currently outlined in lines 190-206: the woman's pregnancy had to be 'normal', without any complications or illnesses (e.g. preeclampsia, gestational diabetes). For your interest, we did not specify that women had to be healthy/free of chronic conditions; the reasoning for this is two-fold: 1) that chronic conditions are not always diagnosed in rural areas due to a lack of access to healthcare, and 2) because we wanted to conduct a pragmatic trial encompassing lactating women in rural Cambodia.
When the research assistants visit the participant's home every two weeks, they are tasked with collecting the old blister pack and completing a short fortnightly questionnaire to record data on compliance (as well as salt disappearance). This questionnaire captures data such as taking multiple capsules in one day, reasons for not taking capsules that remain, and has 'other' options to capture instances such as sharing capsules. Small details such as these have not been included in the manuscript due to word count restraints.
